Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $58 at Goldman Sachs
Tweet
Share
E-mailGet Alerts BHVN Hot Sheet
Price: $14.64 -1.41%
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $58.00 (from $75.00) while maintaining a Buy rating.
You May Also Be Interested In
- Biohaven Pharma (BHVN) PT Raised to $23 at RBC Capital
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
